The role of peptide YY in gastrointestinal diseases and disorders (Review)
- Authors:
- Magdy El-Salhy
- Tarek Mazzawi
- Doris Gundersen
- Jan Gunnar Hatlebakk
- Trygve Hausken
-
Affiliations: Section for Gastroenterology, Department of Medicine, Stord Helse-Fonna Hospital, Stord, Norway, Department of Research, Helse-Fonna, Haugesund, Norway, Section for Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway - Published online on: December 21, 2012 https://doi.org/10.3892/ijmm.2012.1222
- Pages: 275-282
-
Copyright: © El-Salhy et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
This article is mentioned in:
Abstract
Tatemoto K and Mutt V: Isolation and characterization of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature. 285:417–418. 1980. View Article : Google Scholar : PubMed/NCBI | |
Tatemoto K: Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA. 79:2514–2518. 1982. View Article : Google Scholar : PubMed/NCBI | |
Tatemoto K: Neuropeptide Y: the complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA. 79:5485–5489. 1982. View Article : Google Scholar : PubMed/NCBI | |
Tatemoto K, Carlquist M and Mutt V: Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:659–660. 1982. View Article : Google Scholar : PubMed/NCBI | |
Sundler F, Moghimazadeh E, Håkanson R, et al: Nerve fibers in the gut and pancrease of the rat displaying neuropeptide Y immunoreactivity. Intrinsic and extrinsic origin. Cell Tissue Res. 230:487–493. 1983. View Article : Google Scholar : PubMed/NCBI | |
Lundberg JM, Tatemoto K, Terenius L, Hellerström PM, Mutt V, Hökfelt PM and Hemberger B: Localization of polypeptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA. 79:4471–4475. 1982. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M, Grimelius L, Wilander E, Ryberg B, Lundberg JM, Terenius L and Tatemoto K: Immunocytochemical identification of polypeptide YY (PYY) cells in the human gastrointestinal tract. Histochemistry. 77:15–23. 1983. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M: Immunocytochemical investigation of the gastroentero-pancreatic (GEP) neurohormonal peptides in the pancrease and gastrointestinal tract of a cartilaginous fish, the dogfish Squalus achanthias. Histochemistry. 80:193–205. 1984. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M: The occurrence of polypeptide YY (PYY) and pancreatic polypeptide (PP) in the gastrointestinal tract of bony fish. Biomed Res. 5:441–444. 1984. | |
El-Salhy M, Grimelius L, Lundberg JM, Tatemoto K and Terenius L: Immunocytochemical evidence for the occurrence of PYY, a newly isolated gut polypeptide, in endocrine cells in the gut of amphibians and reptiles. Biomed Res. 3:303–306. 1982. | |
El-Salhy M, Wilander E, Abu-Sinna G, Shabaka H, Abu-Sinna G, Lundberg JM and Tatemoto K: On the ontogeny of polypeptide YY (PYY) in the chickens. Biomed Res. 3:680–682. 1982. | |
El-Salhy M, Grimelius L, Wilander E, Lundberg JM, Tatemoto K and Terenius L: The distribution of polypeptide YY (PYY) and pancreatic polypeptide (PP)-immunoreactive cells in the domestic fowl. Histochemistry. 75:25–30. 1982. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M, Wilander E, Juntti-Berggren L and Grimelius L: The distribution and ontogeny of polypeptide YY (PYY) and polypetide (PP)-immunoreactive cells in the gastrointestinal tract of rat. Histochemistry. 78:53–60. 1983. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M and Lundqvist M: Immunocytochemical investigation of polypeptide YY (PYY) and pancreatic polypeptide (PP) in the gastrointestinal tract of three rodents. Biomed Res. 5:401–404. 1984. | |
El-Salhy M and Grimelius L: Immunocytochemical demonstration of polypeptide YY (PYY) in the gastrointestinal tract of the monkey, Macaca rhesus. Biomed Res. 4:289–294. 1983. | |
Sandström O and El-Salhy M: Ontogeny and the effect of aging on pancreatic polypeptide and peptide YY. Peptides. 23:263–267. 2002.PubMed/NCBI | |
El-Salhy M, Suhr O and Danielsson A: Peptide YY in gastrointestinal disorders. Peptides. 23:397–402. 2002. View Article : Google Scholar | |
Ballantyne GH: Peptide YY (1–36) and peptide YY (3–36): Part I. Distribution, release and actions. Obes Surg. 16:651–658. 2006. | |
Grudell ABM and Camilleri M: The role of peptide YY in integrative gut physiology and potent role in obesity. Curr Opin Endocrinol Diabetes Obes. 14:52–57. 2007. View Article : Google Scholar : PubMed/NCBI | |
Batterham RL, Crowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD and Bloom SR: Gut hormone PYY (3–36) physiologically inhibits food intake. Nature. 418:650–654. 2002. | |
Broberger C: Brain regulation of food intake and appetite: molecules and networks. J Intern Med. 258:301–327. 2005. View Article : Google Scholar : PubMed/NCBI | |
McGowan BM and Bloom SR: Peptide YY and appetite control. Curr Opin Pharmacol. 4:583–588. 2004. View Article : Google Scholar : PubMed/NCBI | |
Mannon P and Taylor I: The pancreatic polypeptide family. Gut Peptides: Biochemistry and Physiology. Walsh B and Dockary G: Raven Press; New York: pp. 351–358. 1994 | |
Spiller RC, Trotman IF, Higgins BE, Ghati MI, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ and Silk DBA: The ileal brake-inhibition of jujunal motility after ileal fat perfusion in man. Gut. 25:365–374. 1984. View Article : Google Scholar : PubMed/NCBI | |
Spiller RC, Trotma IF, Adrian TE, Bloom SR, Misiewicz JJ and Silk DB: Further characterisation of the ‘ileal brake’ reflex in man-effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptride YY. Gut. 29:1042–1051. 1988. | |
El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T: Diagnosis, Pathogenesis and Treatment Options. Nova Science Publishers; New York: 2012 | |
El-Salhy M, Gundersen D, Østgaard H, Lomholt-Beck B, Hatlebakk JG and Hausken T: Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci. 57:873–878. 2012. View Article : Google Scholar : PubMed/NCBI | |
Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Greshon MD, Mawe GM and Moses PL: Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 126:1657–1664. 2004. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M, Vaali K, Dizdar V and Hausken T: Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dig Sci. 55:3508–3513. 2010. View Article : Google Scholar : PubMed/NCBI | |
Blackshaw LA and Grundy D: Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst. 45:41–50. 1993. View Article : Google Scholar : PubMed/NCBI | |
Kirchgessner AL, Tamir H and Gershon MD: Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J Neurosci. 12:235–249. 1992.PubMed/NCBI | |
Kirchgessner AL, Liu MT and Gershon MD: In situ identification and visualization of neurons that mediate enteric and enteropancreatic reflexes. J Comp Neurol. 371:270–286. 1996. View Article : Google Scholar : PubMed/NCBI | |
Hillsley K and Grundy D: Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum. J Physiol. 509:717–727. 1998. View Article : Google Scholar : PubMed/NCBI | |
Grundy D, Blackshaw LA and Hillsley K: Role of 5-hydroxytryptamine in gastrointestinal chemosensitivity. Dig Dis Sci. 3(Suppl 12): S44–S47. 1994. View Article : Google Scholar | |
Pan H and Gershon MD: Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci. 20:3295–3309. 2000.PubMed/NCBI | |
Sidhu M and Cooke HJ: Role for 5-HT and ACh in submucosal reflexes mediating colonic secretion. Am J Physiol. 269:G346–G351. 1995.PubMed/NCBI | |
Cooke HJ, Sidhu M and Wang YZ: 5-HT activates neural reflexes regulating secretion in the guinea-pig colon. Neurogastroenterol Motil. 9:181–186. 1997. View Article : Google Scholar : PubMed/NCBI | |
Kim M, Cooke HJ, Javed NH, Carey HV, Christofi F and Raybould HE: D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology. 121:1400–1406. 2001. View Article : Google Scholar : PubMed/NCBI | |
Gershon MD: Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther. 20(Suppl 7): S3–S14. 2004. View Article : Google Scholar : PubMed/NCBI | |
Bearcroft CP, Andre EA and Farthing MJ: In vivo effects of the 5-HT3 antagonist alosetron on basal and cholerat toxin-induced secretion in the human jejunum: a segmental perfusion study. Aliment Pharmacol Ther. 11:1109–1114. 1997. View Article : Google Scholar : PubMed/NCBI | |
Camilleri M: Is there a SERT-ain association with IBS. Gut. 53:1396–1398. 2004. View Article : Google Scholar : PubMed/NCBI | |
Yeo A, Boyd P, Lumsden S, Saunders T, Handley A, Stubbins M, Knaggs A, Asquith S, Taylor I, Bahari B, Crocker N, Rallan R, Varsani S, Montgomery D, Alpers DH, Dukes GE, Purvis I and Hicks GA: Association between a functional polymorphism in the serotonin transporter gene and diarrhea predominant irritable bowel syndrome in women. Gut. 53:1452–1458. 2004. View Article : Google Scholar : PubMed/NCBI | |
Li Y, Nie Y, Xie J, Tang W, Liang P, Sha W, Yang H and Zhou Y: The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci. 52:2942–2949. 2007. View Article : Google Scholar : PubMed/NCBI | |
Park SY, Rew JS, Lee SM, Ki HS, Lee KR, Cheo JH, Kim HI, Noh DY, Joo YE, Kim HS and Choi SK: Association of CCK(1) receptor gene polymorphisms and irritable bowel syndrome in Korean. J Neurogastroenterol Motil. 16:71–76. 2010. View Article : Google Scholar : PubMed/NCBI | |
Wang LH, Fang XC and Pan GZ: Bacillary dysentery as a causative factor for irritable bowel syndrome and its pathogenesis. Gut. 53:1096–1101. 2004. View Article : Google Scholar : PubMed/NCBI | |
Spiller RC, Jenkins D, Thornely JP, Hebden JM, Wright T, Skinner M and Neal KR: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 47:804–811. 2000. View Article : Google Scholar | |
Dunlop SP, Jenkins D, Neal KR and Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 125:1651–1659. 2003. View Article : Google Scholar : PubMed/NCBI | |
Lee KJ, Kim YB, Kwon HC, Kim DK and Cho SW: The alteration of enterochromaffin cell, mast cell and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol. 3:1689–1694. 2008.PubMed/NCBI | |
Kim HS, Lim JH, Park H and Lee SI: Increased immunoreactive cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection - an observation in a small case control study. Yonsei Med. 51:45–51. 2009. | |
Dizdar V, Spiller R, Hanevik K, Gilja OH, El-Salhy M and Hausken T: Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 31:883–891. 2010.PubMed/NCBI | |
Liszka L, Woszczyk D and Pajak J: Histopathological diagnosis of microscopic colitis. J Gastroenterol Hepatol. 21:792–797. 2006. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M, Danielsson A, Stenling R and Grimelius L: Colonic endocrine cells in inflammatory bowel disease. J Intern Med. 242:413–419. 1997. View Article : Google Scholar : PubMed/NCBI | |
Böttcher G, Alumets J, Håkanson R and Sundler F: Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study. Regul Pept. 13:283–291. 1986.PubMed/NCBI | |
Ali-Rachedi A, Varndell MI, Adrian TE, Gapp DA, van Noorden S, Bloom SR and Polak JM: Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry. 80:487–491. 1984. View Article : Google Scholar : PubMed/NCBI | |
Nilsson O, Bilchik AJ, Goldenring JR, Ballantyne GH, Adrian TE and Modlin IM: Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon. Endocrinology. 129:139–148. 1991. View Article : Google Scholar : PubMed/NCBI | |
Lu SJ, Liu YQ, Lin JS, Wu HJ, Sun YH and Tan YB: VIP immunoreactive nerve and somatostatin and serotonin containing cells in Crohn’s disease. World J Gastroenterol. 5:541–543. 1999.PubMed/NCBI | |
Stoyanova II and Gulubova MV: Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem. 104:185–192. 2002. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T: High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol. 18:6070–6075. 2012. View Article : Google Scholar : PubMed/NCBI | |
Qian BF, El-Salhy M, Melgar S, Hammarström ML and Danielsson A: Neuroendocrine changes in colon of mice with a disrupted IL-2 gene. Clin Exp Immunol. 120:424–433. 2000. View Article : Google Scholar : PubMed/NCBI | |
Hirotani Y, Mikajiri K, Ikeda K, Myotoku M and Kurokawa N: Changes in the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone. Yakugaku Zasshi. 128:1347–1353. 2008. View Article : Google Scholar : PubMed/NCBI | |
Spiller R: Serotonin, inflammation, and IBS: fitting the jigsaw together? J Pediatr Gastroenterol Nutr. 45(Suppl 2): S115–S119. 2007. View Article : Google Scholar : PubMed/NCBI | |
Khan WI and Ghia JE: Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol. 161:19–27. 2010.PubMed/NCBI | |
Yang GB and Lackner AA: Proximity between 5HT secreting enteroendocrine cells and lymphocytes in gut mucosa of rhesus macaques (Macaca mulatta) is suggestive of a role for enterochromaffin cell 5HT in mucosal immunity. J Neuroimmunol. 146:46–49. 2004. View Article : Google Scholar : PubMed/NCBI | |
MacDonald A, Baxter JN and Finlay IG: Idiopathic slow-transit constipation. Br J Surg. 80:1107–1111. 1993. View Article : Google Scholar | |
El-Salhy M: Chronic idiopathic slow transit constipation: pathophysiology and management. Colorectal Dis. 5:288–296. 2003. View Article : Google Scholar : PubMed/NCBI | |
Bassotti G, Gaburri M, Imbimbo BP, Rossi L, Faroni F, Pelli MA and Morelli A: Colonic mass movement in idiopathic chronic constipation. Gut. 29:1173–1178. 1988. View Article : Google Scholar : PubMed/NCBI | |
Bassotti G, Betti C, Pelli MA and Morelli A: Prolonged (24-hour) manometeric recording of rectal contractile activity in patients with slow transit constipation. Digestion. 49:72–77. 1991. View Article : Google Scholar : PubMed/NCBI | |
Bassotti G, Chiarioni G, Imbimbo BP, Betti C, Bonfante F, Vantini I, Morelli A and Whitehead WE: Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci. 38:1040–1045. 1993. View Article : Google Scholar : PubMed/NCBI | |
Bazocchi IG, Ellis J, Meyer J, Mena I, Reddy SN and Morento-Osset E: Colonic scintigraphy and manometry in constipation, diarrhea and inflammatory bowel disease. Gastroenterology. 94:A291988. | |
Klauser AG, Peyerl C, Schindbeck NE and Müller-Lissner SA: Nutrition and physical activity in chronic constipation. Eur J Gastroenterol Hepatol. 4:227–233. 1992. | |
Sjölund K, Fasth S, Ekman R, Hulten L, Jiborn H, Nordgren S and Sundler F: Neuropeptides in idiopathic chronic (slow transit constipation). Neurogastroenterol Motil. 9:143–150. 1997. | |
El-Salhy M, Norrgård Ö and Spinnell S: Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol. 34:1007–1011. 1999. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M and Norrgård Ö: Colonic neuroendocrine peptide levels in patients with chronic idiopathic slow transit constipation. Ups J Med Sci. 103:223–230. 1998. View Article : Google Scholar : PubMed/NCBI | |
Tough IR and Cox HM: Selective inhibition of neuropeptide Y Y1, receptors by B1BP3226 in rat and human epithelial preparations. Eur J Pharmacol. 310:55–60. 1996. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M: The nature and implication of intestina1 endocrine cell changes in coeliac disease. Histol Histopathol. 13:1069–1075. 1998.PubMed/NCBI | |
Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS and Bloom SR: Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology. 90:379–384. 1986.PubMed/NCBI | |
Sjölund K and Ekman R: Increased plasma level of peptide YY in coeliac disease. Scand J Gastroenterol. 23:297–300. 1988.PubMed/NCBI | |
Adrian TE, Thompson JS and Quigley EM: Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog. Dig Dis Sci. 41:1194–1203. 1996. View Article : Google Scholar : PubMed/NCBI | |
Enck P, Rathmann W, Spiekermann M, Czener D, Tschöpe D, Ziegler D, Strohmeyer G and Gries FA: Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 32:637–641. 1996.PubMed/NCBI | |
Feldman M and Schiller LR: Disorders of gastrointestina1 motility associated with diabetes mellitus. Ann Intern Med. 98:378–384. 1983. View Article : Google Scholar : PubMed/NCBI | |
Locke GR III: Epidemiology of gastrointestinal complications of diabetes mellitus. Eur J Gastroenterol Hepatol. 7:711–716. 1995.PubMed/NCBI | |
Schwartz E, Palmér M, Ingberg CM, Åman J and Berne C: Increased prevalence of gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med. 13:478–781. 1996. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M: The possible role of the gut neuroendocrine system in diabetes gastroenteropathy. Histol Histopathol. 17:1153–1161. 2002.PubMed/NCBI | |
El-Salhy M: Overview of diabetic gastroenteropathy. Geriatric Times. 4:15–16. 2003. | |
El-Salhy M: Gut neuroendocrine system in diabetes gastroenteropathy: possible role in pathophysiology and clinical implications. Focus on Diabetes Research. Ashley M: Nova Science Publishers; New York: pp. 79–102. 2006 | |
El-Salhy M and Sitohy B: Abnormal gastrointestinal endocrine cells in patients with diabetes type 1: relationship to gastric emptying and myoelectrical activity. Scand J Gastroenterol. 36:1162–1169. 2001. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M: Neuroendocrine peptides in stomach and colon of an animal model for human diabetes type 1. J Diabetes Complications. 13:170–173. 1999. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M: Gastrointestinal transit in non-obese diabetic mouse: an animal model of human diabetes type l. J Diabetes Complications. 15:277–284. 2001. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M: Gastric emptying in an animal model of human diabetes type 1: relation to endocrine cells. Acta Diabetol. 38:139–144. 2001. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M: Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetol. 35:194–198. 1998. View Article : Google Scholar : PubMed/NCBI | |
Portela-Gomes GM, Wilander E, Grimelius L, Bergström R and Ruhn G: The enterochromaffin cells in the mouse gastrointestinal tract after streptozotocin treatment. Pathol Res Pract. 186:260–264. 1990. View Article : Google Scholar : PubMed/NCBI | |
Sitohy B and El-Salhy M: Colonic endocrine cells in rats with chemically induced colon carcinoma. Histol Histopathol. 16:833–838. 2001.PubMed/NCBI | |
El-Salhy M and Wilander E: Colonic neuroendocrine peptides in rats with chemically-induced colon carcinoma. GI Cancer. 3:73–78. 1999. | |
El-Salhy M, Norrgård O and Boström A: Low levels of colonic somatostatin and galanin in patients with colon carcinoma. GI Cancer. 2:221–225. 1998. | |
El-Salhy M, Mahdavi J and Norrgård Ö: Colonic endocrine cells in patients with carcinoma of the colon. Eur J Gastroenterol Hepatol. 10:517–522. 1998. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M, Norrgård Ö, Franzén L and Forsgren S: Colonic endocrine cells in patients with carcinoma of the rectum with special regard to preoperative irradiation. GI Cancer. 2:285–292. 1998. | |
Baldwin GS and Whitehead RH: Gut hormones, growth and malignancy. Baillieres Clin Endocrinol Metab. 8:185–214. 1994. View Article : Google Scholar : PubMed/NCBI | |
Björk J, Nilsson R, Hultcranz R and Johansson C: Growth regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on non-transformed intestinal epithelial cell line IEC-6, and colon cancer cell line HT 29. Scand J Gastroenterol. 28:879–884. 1993. | |
El-Salhy M: Triple treatment with octreotide, galanin and serotonin is a promising therapy for colorectal cancer. Curr Pharma Des. 11:2107–2117. 2005. View Article : Google Scholar : PubMed/NCBI | |
Anan I: The neuroendocrine system in patients with familial amyloidotic polyneuropathy. (unpublished PhD thesis) Umeå University Medical Dissertations. 2000 | |
Anan I, El-Salhy M, Ando Y, Nyhlin N, Terazaki H, Sakashita N and Suhr O: Colonic endocrine cells in patients with familial amyloidotic polyneuropathy. J Intern Med. 245:469–473. 1999. View Article : Google Scholar : PubMed/NCBI | |
El-Salhy M and Suhr O: Enocrine cells in rectal biopsy specimens from patients with familial amyloidotic polyneuropathy. Scand J Gastroenterol. 31:68–73. 1996. View Article : Google Scholar : PubMed/NCBI | |
Rönnblom A, Danielsson Å and EI-Salhy M: Intestinal endocrine cells in myotonic dystrophy: an immunohistochemical and computed image ana1ytical study. J Intern Med. 245:91–97. 1999. | |
Andersson R: Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl. 590:1–64. 1976.PubMed/NCBI | |
Steen L and Ek B: Familial amyloidosis with polyneuropathy. A long term follow-up of 21 patients with reference to gastrointestinal symptoms. Acta Med Scand. 214:387–397. 1983. View Article : Google Scholar : PubMed/NCBI | |
Suhr O, Danielsson Å and Steen L: Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy. Scand J Gastroenterol. 27:201–207. 1992. View Article : Google Scholar : PubMed/NCBI | |
Akesson A and Ekman R: Gastrointestinal regulatory peptides in systemic sclerosis. Arthritis Rheum. 36:698–703. 1993. View Article : Google Scholar : PubMed/NCBI | |
Yamashita Y, Toge T and Adrian TH: Gastrointestinal hormone in dumping syndrome and reflux esophigitis after gastric surgery. J Smooth Muscle Res. 33:37–48. 1997. View Article : Google Scholar : PubMed/NCBI | |
Andrews NJ and Irving MH: Human gut hormone profiles in patients with short bowel syndrome. Dig Dis Sci. 37:729–732. 1992. View Article : Google Scholar : PubMed/NCBI | |
Pietroletti R, Slores FJ, Mariani P, Leard IS, Simi M and Brummelkamp WH: Enteroglucagon and peptide YY response after construction of pelvic reservoir in humans. Dis Colon Rectum. 33:966–969. 1990. View Article : Google Scholar : PubMed/NCBI | |
Soper NJ, Chapman NJ, Kelly K, Brown ML, Phillips SF and Go VL: The ‘ileal brake’ after ileal pouch-anal anastomosis. Gastroenterology. 98:111–116. 1990. | |
Healey KL, Bines JE, Thomas SL, Wilson G, Taylor RG, Sourial M and Pereira-Fantini PM: Morphological and functional changes in the colon after massive small bowel resection. J Pediatr Surg. 45:1581–1590. 2010. View Article : Google Scholar : PubMed/NCBI | |
Liu CD, Aloia T, Adrian TE, Newton TR, Bilchik AJ, Zinner MJ, Ashley SW and McFadden DW: Peptide YY: a potential proabsorptive hormone for the treatment of malabsorption disorders. Am Surg. 62:232–236. 1996.PubMed/NCBI | |
Liu CD, Hines OJ, Whang EE, Balasubramanian A, Newton TR, Zinner MJ, Ashley SW and McFadden DW: A novel synthetic analog of peptide YY, BIM-43004, given intraluminally, is proabsorptive. J Surg Res. 59:80–84. 1995. View Article : Google Scholar : PubMed/NCBI | |
Degen L, Oesch S, Casanova M, Graf S, Ketterer S, Drewe J and Beglinger C: Effect of peptide YY3-36 on food intake in humans. Gastroenterology. 129:1430–1436. 2005. View Article : Google Scholar : PubMed/NCBI |